These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17316466)

  • 1. Bolus or continuous hydrocortisone--that is the question.
    Weber-Carstens S; Keh D
    Crit Care; 2007; 11(1):113. PubMed ID: 17316466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.
    Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E
    Crit Care; 2007; 11(1):R21. PubMed ID: 17306016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose control in sepsis.
    Thompson BT
    Clin Chest Med; 2008 Dec; 29(4):713-20, x. PubMed ID: 18954705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
    ; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
    JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients.
    Fuchs PCh; Bozkurt A; Johnen D; Smeets R; Groger A; Pallua N
    Burns; 2007 May; 33(3):306-11. PubMed ID: 17382191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin therapy in septic shock.
    Orford NR
    Crit Care Resusc; 2006 Sep; 8(3):230-4. PubMed ID: 16930111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids in sepsis: a new concept for an old drug.
    Klaitman V; Almog Y
    Isr Med Assoc J; 2003 Jan; 5(1):51-5. PubMed ID: 12592960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-dose hydrocortisone treatment of catecholamine refractory septic shock].
    Strelzig JD; Stender-Baals M; Lohse TO
    Ugeskr Laeger; 2001 Sep; 163(36):4880-1. PubMed ID: 11571866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients.
    Weber-Carstens S; Deja M; Bercker S; Dimroth A; Ahlers O; Kaisers U; Keh D
    Intensive Care Med; 2007 Apr; 33(4):730-3. PubMed ID: 17325831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
    Raurich JM; Llompart-Pou JA; Ibáñez J; Frontera G; Pérez O; García L; Ayestarán JI
    J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
    Valoor HT; Singhi S; Jayashree M
    Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy with hydrocortisone in catecholamine-dependent septic shock.
    Annane D
    J Endotoxin Res; 2001; 7(4):305-9. PubMed ID: 11717587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability.
    Waeschle RM; Moerer O; Hilgers R; Herrmann P; Neumann P; Quintel M
    Crit Care; 2008; 12(5):R129. PubMed ID: 18939991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid therapy of septic shock.
    Sprung CL; Goodman S; Weiss YG
    Crit Care Clin; 2009 Oct; 25(4):825-34, x. PubMed ID: 19892255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
    Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
    Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Septic shock: blood glucose regulation].
    Orban JC; Deroche D; Ichai C
    Ann Fr Anesth Reanim; 2006 Mar; 25(3):275-9. PubMed ID: 16298101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison Between Continuous and Intermittent Administration of Hydrocortisone During Septic Shock: A Randomized Controlled Clinical Trial.
    Tilouche N; Jaoued O; Ali HBS; Gharbi R; Fekih Hassen M; Elatrous S
    Shock; 2019 Nov; 52(5):481-486. PubMed ID: 30628950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing hydrocortisone and methylprednisolone in patients with septic shock.
    Yu TJ; Liu YC; Yu CC; Tseng JC; Hua CC; Wu HP
    Adv Ther; 2009 Jul; 26(7):728-35. PubMed ID: 19629409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.